NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Encompass and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On ...

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On July 17, 2025, GSK issued a press ...

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Dow and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 24, 2025, Dow issued a press ...

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether MarineMax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On July 24, ...

Key Takeaways New Gold shares touched $5.33, fueled by strong Q2 and higher gold prices.NGD revenues jumped 41.3% in Q2 to $308M on stronger gold sales and prices.NGD posted a record $63M free cash flow and advanced the New Afton and Rainy River projects.New Gold Inc. (NGD) shares scaled a new 52-week high of $5.33 on Wednesday before closing the session lower at $5.26. The increase was fueled by rising gold prices and the company’s solid second-quarter 2025 results.NGD has a market capitalization of $4.16 ...

Key Takeaways Microbot gained a U.S. patent expanding LIBERTY's applications with modular tool-receiver units.The new patent increases Microbot's U.S. market opportunity from 2.5M to over 6M procedures.Shares have risen 7.1% after the news, with year-to-date gains of 195.5% against industry decline.Microbot Medical Inc. (MBOT) has been granted a new U.S. patent that broadens the potential applications of its LIBERTY Endovascular Robotic System. The patent covers a modular design that allows interchangeable ...

Key Takeaways AngioDynamics delivered stronger-than-expected Q4 revenue and a narrower adjusted loss per share.NanoKnife drives growth with FDA clearance, rising disposable sales, and future reimbursement catalysts.Auryon, AlphaVac, and AngioVac growth plus steady legacy products support a resilient revenue base.AngioDynamics (ANGO) has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid fourth-quarter fiscal 2025 performance, ...

Coty's latest quarterly report arrived with news that's causing investors to abandon the stock.Coty (COTY -20.89%) stock is getting crushed in Thursday's trading. The beauty products and fragrance company's share price was down 22.3% as of 2 p.m. ET. amid the backdrop of a 0.4% loss for the S&P 500 (^GSPC -0.32%).After the market closed yesterday, Coty published results for the fourth quarter of its last fiscal year, which ended June 30. While the company posted sales that topped Wall Street's expectations, ...

Miniso Group Holding Limited (NYSE: MNSO ) recently reported Q4 earnings , which beat expectations as its overseas growth remains the highlight of operations. I wanted to go through the numbers and some comments onMSc in Finance. Long-term horizon investor mostly with 5-10 year horizon. I like to keep investing simple. I believe a portfolio should consist of a mix of growth, value, and dividend-paying stocks but usually end up looking for value more than anything. I also sell options from time to time.Analy ...

Key Takeaways DY's Q2 EPS of $3.33 beat estimates by 16.4% and rose 35.4% y/y on better operating leverage.Contract revenues rose 14.5% y/y but missed estimates, leading to a 4.6% drop in DY stock.DY reaffirmed FY26 guidance, backed by digital infrastructure growth and a 20%+ rise in 12-month backlog.Dycom Industries Inc. (DY) reported mixed results in second-quarter fiscal 2026 (ended July 26, 2025) with quarterly earnings surpassing the Zacks Consensus Estimate and also increasing on a year-over-year basi ...